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a b s t r a c t
The inﬂuenza A virus NS1 protein has a nuclear localization sequence (NLS) in the amino terminal region.
This NLS overlaps sequences that are important for RNA binding as well as protein dimerization.
To assess the signiﬁcance of the NS1 NLS on inﬂuenza virus replication, the NLS amino acids were
individually mutated to alanines and recombinant viruses encoding these mutations were rescued.
Viruses containing NS1 proteins with mutations at R37, R38 and K41 displayed minimal changes in
replication or NS1 protein nuclear localization. Recombinant viruses encoding NS1 R35A were not
recovered but viruses containing second site mutations at position D39 in addition to the R35A mutation
were isolated. The mutations at position 39 were shown to partially restore NS1 protein dimerization but
had minimal effects on nuclear localization. These data indicate that the amino acids in the NS1 NLS
region play a more important role in protein dimerization compared to nuclear localization.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The RNA genome of inﬂuenza A virus is replicated in the nucleus
of infected cells (Taylor et al., 1977). The inﬂuenza NS1 protein has
been shown to localize to the nucleus and cytoplasm of infected cells
through two identiﬁed nuclear localization sequences (NLS) as well as
a nuclear export sequence (NES) (Melen et al., 2007; Han et al., 2010;
Forbes et al., 2013). A classic monopartite NLS, NLS1, is found between
amino acids 34 and 41 and is highly conserved among inﬂuenza A
virus strains. It contains four basic amino acids, R35, R37, R38, and
K41 (Greenspan et al., 1988; Melen et al., 2007). Of these, R35, R38,
and K41 have been shown to decrease interaction with importin-α if
mutated to alanine (Melen et al., 2007). The second NLS (NLS2), is
bipartite, located between amino acids 219 and 232 and is virus strain
speciﬁc (Greenspan et al., 1988; Melen et al., 2007, 2012). The NES is
located between amino acids 138 and 147 (Li et al., 1998). A virus
strain speciﬁc nucleolar localization (NoLS) signal has also been
identiﬁed which overlaps with NLS2 (Melen et al., 2007, 2012; Zhu
et al., 2013).
The NS1 protein is divided into two functional domains (Qian
et al., 1994). The ﬁrst 73 amino acids form the RNA binding domain
while amino acids after position 74 form the effector domain
(Qian et al., 1995). The RNA binding domain interacts with at least
four RNA targets: dsRNA, polyA sequence, U6snRNA, and u6atac
snRNA (Wang et al., 1999) and it is important for antagonizing the
innate immune response in both the cytoplasm and the nucleus
(reviewed in Hale et al., 2008). Arginine at position 38 is critical for
binding RNA and mutating this amino acid to alanine results in loss of
RNA binding (Wang et al., 1999; Melen et al., 2007). This loss in RNA
binding results in viruses that are more sensitive to exogenous
interferon beta treatment and virus-infected cells produce more type
I interferon and cytokines than wild type virus-infected cells (Wang
et al., 1999; Donelan et al., 2003; Min and Krug, 2006; Newby et al.,
2007). NS1 interaction with RNA also requires that the protein form a
dimer (Nemeroff et al., 1995; Wang et al., 1999) and a number of
amino acids in the effector domain (Wang et al., 2002) and the RNA
binding domain (Wang et al., 1999) contribute to protein dimeriza-
tion. Of particular interest for dimerization is arginine at position 35
which is also part of NLS1 (Melen et al., 2007).
Consistent with having both NLS and NES signals, the NS1 protein
has functions in both the nucleus and cytoplasm and can trafﬁc
between the compartments (Melen et al., 2007; Han et al., 2010;
Forbes et al., 2013). In the nucleus, NS1 inhibits cellular mRNA
maturation through interactions with multiple host factors. Interac-
tions with cleavage and polyadenylation speciﬁcity factor (CPSF) and
polyadenine binding protein II (PABPII) prevent cleavage and poly-
adenylation of cellular mRNAs (as reviewed in Hale et al., 2008),
while interactions with the mRNA splicing machinery and nuclear
export factors further limit cellular mRNA maturation and export
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(Satterly et al., 2007). NS1 also colocalizes with ND10 in nuclear dots
and interacts with nucleolin (Sato et al., 2003; Murayama et al., 2007).
In the cytoplasm, NS1 interacts with a number of cellular pathways.
Some of these pathways, including 2050OAS/RNase L, Rig-I/Trim25 and
PKR inhibit host anti-viral responses (Donelan et al., 2003; Li et al.,
2006; Min and Krug, 2006; Kochs et al., 2007; Min et al., 2007; Opitz
et al., 2007; Gack et al., 2009). NS1 also interacts with eIF4GI, PABPI,
hnRNP-f and hStaufen to increase viral protein synthesis (Lee et al.,
2009; reviewed in Hale et al., 2008).
To study the role of the inﬂuenza NS1 N terminal NLS on virus
replication, a series of mutations were introduced into four basic
amino acids (R35, R37, R38 and K41) in the NLS1 and recombinant
inﬂuenza A/WSN/33 viruses encoding these mutated proteins were
rescued and characterized. Viruses encoding the R37A, R38A and
K41A mutations were recovered and had minimal effects on virus
replication and NS1 nuclear localization. Recombinant viruses with
the R35A mutation were only rescued when spontaneous, second site
mutations at position D39 arose. Our data indicate that the amino
acids comprising the NS1 NLS1 have minimal effects on NS1 nuclear
localization, but at least one, R35, plays an important role in protein
dimerization. We demonstrate that second site mutations at position
D39 are able to correct for a loss in dimerization caused by the R35A
mutation, thereby restoring virus replication.
Results
Rescue of recombinant viruses with mutations in NS1 NLS1
The A/WSN/33 NS1 protein only encodes an amino terminal
NLS (NLS1). In order to study the effects of these amino acids on
inﬂuenza virus replication, the basic amino acids in NLS1 were
mutated to alanine, generating plasmids encoding NS1 R35A,
R37A, R38A, and K41A (Table 1, top half “NLS”). A virus with the
NS1 R38A mutation (rWSN NS1 R38A), which disrupts both NLS1
and RNA binding, was previously isolated (Newby et al., 2007). The
rWSN NS1 R37A and rWSN NS1 K41A viruses were successfully
rescued and plaque puriﬁed. The rWSN NS1 R35A virus was not
isolated in three separate rescue attempts, but recombinant
viruses with amino acid substitutions at position 39 of NS1
(D39A, D39N, or D39Y, Table 1, bottom half collectively referred
to as “D39X”) in addition to the R35A mutation were isolated. The
mutations were all the result of single nucleotide changes from
wild type GAU (D) to GCU (A), AAU (N) or TAU (Y).
Nuclear localization mutations have minor effects on virus replication
in MDCK cells
To study the effect of alanine substitutions in the NS1 NLS1 on
virus replication, MDCK cells were infected at a multiplicity of
infection (MOI) of 0.001 and virus production was monitored
every 12 h by TCID50 assay (Fig. 1A). There were no differences
in replication between any of the rescued viruses (Fig. 1A).
As another measure of virus replication, virus plaque diameter
Fig. 1. NS1 NLS viruses replicate to high titers on MDCK and Vero cells lines. (A) MDCK
cells were infected with rWSN or rWSN NS1 NLS viruses at a MOI of 0.001 TCID50/cell.
Supernatants were collected every 12 h and virus titers were analyzed by TCID50 assay.
The limit of detection is indicated by a dotted line at 1.67 and mean and standard error
of the mean are graphed. There were no statistical differences in virus replication (two-
way ANOVA). (B) MDCK cells were infected with serial dilutions of rWSN or rWSN NS1
NLS viruses and incubated under 1% agarose and media for three days then ﬁxed.
Plaque diameter was measured using ImageJ. Individual plaques are graphed and mean
diameter is indicated with a solid horizontal line. Signiﬁcant differences relative to
rWSN are indicated with an asterisk (n), po0.01, one-way ANOVA and a Bonferroni
multiple comparison post test. (C) Vero cells were infected with rWSN or rWSN NS1
NLS viruses at a MOI of 0.001 TCID50/cell. Supernatants were collected every 24 h and
virus titers were analyzed by TCID50 assay. The limit of detection is indicated by a
dotted line at 1.67 and mean and standard error of the mean are graphed. There were
no statistical differences in virus replication using a two-way ANOVA and a Bonferroni
multiple comparison post test.
Table 1
Inﬂuenza NS1 sequence and mutations.
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was determined on MDCK cells (Fig. 1B). While the rWSN R38A
virus had smaller plaque diameter than rWSN (Newby et al.,
2007), the rWSN R37A and rWSN K41A viruses had plaque
diameters similar to rWSN. There were no differences in virus
replication in Vero cells after infection with an MOI of 0.001
(Fig. 1C). Taken together, these data indicate that viruses encoding
NS1 protein with R37A and K41A mutations replicate in MDCK and
Vero cells similarly to wild type virus. The NS1 R38A mutation
slightly attenuates virus replication, as previously demonstrated
(Newby et al., 2007).
The levels of NS1 protein expression were not affected by the
NLS mutations as determined by western blot (Fig. 2A) or mean
ﬂorescent intensity (MFI) by ﬂow cytometry (Fig. 2B) at six hours
post infection with an MOI of 5. To determine whether the alanine
substitutions disrupted NS1 nuclear localization, MDCK cells were
infected at an MOI of 5 for 6 h, and then examined by immuno-
ﬂorescence microscopy. The NS1 protein from wild type and NLS
viruses was found in both the nucleus and the cytoplasm of
infected cells. As previously described, some of the cells infected
with the rWSN NS1 R38A virus displayed punctate concentrations
of NS1 throughout the cytoplasm (Newby et al., 2007). The NS1
wild type protein was found in the nucleolus of some infected cells
and a loss of nucleolar localization was observed for cells infected
with rWSN NS1 R38A and rWSN NS1 K41A. Nucleolar localization
was unaffected in rWSN NS1 R37A infected cells (Fig. 2C). Previous
reports have identiﬁed little nucleolar localization of NS1 in rWSN
infected cells which is consistent with our data at 3 hours post
infection (data not shown) (Melen et al., 2007; Newby et al., 2007).
Nucleolar localization was observed in some cells from 6 to 12
hours post infection (data not shown). Therefore, while mutations
to R38 and K41 have been characterized to attenuate NS1 function
and recombinant virus replication, they seem to have a minimal
effect on nuclear localization of the protein in virus-infected
MDCK cells.
Viruses with NS1 R35A D39X mutations have altered NS1 subcellular
localization patterns
The viruses with NS1 R35A D39X mutations were tested for
virus replication, NS1 protein expression and localization
(Figs. 3 and 4). The rWSN NS1 R35A D39A virus had similar
replication kinetics and peak titers of infectious virus relative to
rWSN, while the rWSN NS1 R35A D39N and rWSN R35A D39Y
viruses showed reduced replication (Fig. 3A). When plaque dia-
meters were measured, only the rWSN NS1 R35A D39Y virus had
signiﬁcantly smaller plaque diameters when compared to rWSN
(Fig. 3B). All the viruses replicated with similar kinetics and to a
similar extent in Vero cells (Fig. 3C).
To examine NS1 protein expression levels, MDCK cells were
infected at an MOI of 5 and processed for western blot and ﬂow
cytometry 6 hours post infection. No signiﬁcant difference was
Fig. 2. The NS1 protein is expressed at comparable amounts and is not excluded from the nucleus by NLS mutations during infection. (A) MDCK cells were infected with
rWSN or rWSN NS1 NLS viruses at a MOI of 5 TCID50/cell. At 6 hpi, the cells were lysed in 1% SDS and NS1 expression was examined by western blot. (B) MDCK cells were
infected with rWSN or rWSN NS1 NLS viruses at an MOI of 5 TCID50/cell. At 6 hpi, NS1 expression was quantiﬁed by ﬂow cytometry. The mean ﬂuorescence intensity (MFI) of
the NS1 positive cells was normalized to wt and the mean and standard error of the mean are graphed. There was no statistical difference using a one-way ANOVA and a
Bonferroni multiple comparison post test. (C) MDCK cells were grown on glass coverslips and infected with rWSN or rWSN NS1 NLS viruses at a MOI of 5 TCID50/cell. The
cells were ﬁxed at 6 hpi and NS1 localization was determined by immunoﬂuorescence microscopy using deconvolution of serial optical sections. All images were taken with
a 100 objective and DAPI was used to counterstain the nucleus. Mock-infected MDCK cells were included in all experiments and showed no reactivity with the NS1
antibodies.
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observed in the levels of NS1 protein expression (Fig. 4A and B),
suggesting that altered NS1 protein levels were not responsible for
the reduced virus replication of rWSN NS1 D35A D39N/Y viruses.
NS1 subcellular localization was next examined in MDCK cells six
hours after a MOI 5 infection. In a portion of infected cells, all three
NS1 R35A D39X viruses formed ﬂuorescent puncta in the cyto-
plasm not observed in wild type rWSN-infected cells (Fig. 4C).
Similar to rWSN NS1 R38A- and K41A-infected cells (Fig. 2C), no
nucleolar localization was seen in the D39X infected cells (Fig. 4C).
These results indicate that rWSN NS1 R35A D39X viruses are able
to replicate and express similar levels of NS1 protein compared to
wild type virus but NS1 localization is affected. Similar to other
viruses with mutations to NLS1, the NS1 protein was not excluded
from the nucleus by R35A D39X mutations.
Plasmid expressed NS1 R35A and R35A D39X proteins show similar
localizations
To explore how the NS1 R35A and D39X mutations were
affecting NS1 expression and function, the proteins were
expressed from cDNA expression vectors. Protein localization
was examined by transfecting MDCK cells with wild type NS1,
NS1 R35A, or one of the NS1 R35A D39X plasmids. Subcellular
localization of NS1 R35A and the NS1 R35A D39X proteins at
9 hours post transfection was similar for wild type and mutant
NS1 (Fig. 5), with no obvious change in nuclear localization being
apparent. The distinct brightly ﬂuorescent puncta seen in rWSN
NS1 R35A D39X infected cells were not observed after cDNA
expression of the proteins, indicating that the puncta form either
in response to the expression of other viral proteins or are due to
cellular responses to virus infection. The NS1-myc protein dis-
played a similar intracellular localization pattern as the wild type
NS1 protein (data not shown). The expression level of the NS1
proteins in transfected cells was examined by ﬂow cytometery
(Fig. 6). Similar to virus infection, the expression levels of the NS1
R35A D39X proteins are not signiﬁcantly different than wild type
protein. The expression of NS1 R35A was signiﬁcantly lower than
any of the other NS1 proteins (Fig. 6), indicating that the R35A
mutation reduces NS1 protein levels, presumably due to greater
amounts of protein degradation, and that the D39X mutations are
restoring protein expression levels.
The NS1 R35A mutation reduces protein dimerization and mutations
at amino acid 39 restore this activity
Because a virus encoding only the NS1 R35A mutation was not
rescued, it was hypothesized that the D39 mutations compensate
for a loss of NS1 dimerization, as R35Awas previously identiﬁed as
critical for dimerization of the NS1 RNA binding domain (Wang
et al., 1999). To determine if the mutations at D39 correct for loss
of dimerization, a bimolecular ﬂorescent complementation (BiFC)
assay was used (Kerppola, 2006). The NS1 wild type and mutant
proteins were fused to either the N- (YFP1) or C-terminal (YFP2)
fragments of YFP (Fig. 7A). If the NS1 proteins interact, the
ﬂorescent protein fragments will be brought into close proximity
and refold to produce a complete, ﬂuorescent YFP protein
(Hu et al., 2002).
To determine if RNA dimerization is reduced with a NS1 R35A
mutation (Wang et al., 1999), cells were transfected with plasmids
encoding YFP1-NS1 and YFP2-NS1 (Fig. 7A, constructs with black
NS1) or YFP1-NS1 R35A and YFP2-NS1 R35A (Fig. 7A constructs
with white NS1). Transfected cells were ﬁxed and processed for
ﬂow cytometery nine hours after transfection. NS1 expressing cells
were gated on and analyzed for NS1 expression levels. Both sets of
constructs expressed similar amount of NS1 protein (Fig. 7C black
and white bars). YFP expression in cells expressing NS1 R35A
fusion proteins was signiﬁcantly lower than that observed in cells
expressing NS1 wild type fusion proteins (Fig. 7B), indicating loss
of NS1 dimerization in the NS1 R35A mutant protein. The YFP MFI
Fig. 3. NS1 R35A D39X viruses replicate to high titers and express comparable
amounts of NS1 protein. (A) MDCK cells were infected with rWSN or rWSN NS1
R35A D39X viruses at a MOI of 0.001 TCID50/cell. Supernatants were collected every
12 h and virus titers were analyzed by TCID50 assay. The limit of detection is
indicated by a dotted line at 1.67 and mean and standard error of the mean are
graphed. Signiﬁcant differences between the replication of NS1 R35A D39X viruses
and wild type virus are indicated with an asterisk (n), po0.01, two-way ANOVA
and a Bonferroni multiple comparison post test. (B) Plaque diameter in MDCK cells
was measured using ImageJ. Individual plaques are graphed and mean diameter is
indicated with a solid horizontal line. Signiﬁcant differences between NS1 R35A
D39X viruses and rWSN are indicated with an asterisk (n), po0.01, one-way
ANOVA and a Bonferroni multiple comparison post test. (C) VERO cells were
infected with rWSN or rWSN NS1 NLS viruses at a MOI of 0.001 TCID50/cell.
Supernatants were collected every 24 h and virus titers were analyzed by TCID50
assay. The limit of detection is indicated by a dotted line at 1.67 and mean and
standard error of the mean are graphed. There were no statistical differences in
virus replication using a two-way ANOVA and a Bonferroni multiple comparison
post test.
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for NS1 R35A constructs is similar to background ﬂuorescence
levels measured by transfecting cells with plasmids expressing
YFP1 and YFP2-NS1 (Fig. 7B dotted line).
To determine if the loss of dimerization occurs if only one of
the NS1 molecules in a dimer has the R35A mutation, cells were
transfected with plasmids encoding YFP1-NS1 and YFP2-NS1 R35A
Fig. 4. The NS1 protein is expressed at comparable amounts though intracellular localization of the NS1 protein is altered by the D39X mutations during infection. (A) MCDK
cells were infected with rWSN or rWSN NS1 D39X viruses at a MOI of 5 TCID50/cell. At 6 hpi, the cultures were lysed in 1% SDS and NS1 expression was examined by western
blot. (B) MCDK cells were infected with rWSN or rWSN NS1 D39X viruses at a MOI of 5 TCID50/cell. At 6 hpi, NS1 expression was quantiﬁed by ﬂow cytometry. The MFI of the
NS1 positive cells was normalized to wild type and the mean and standard error of the mean are graphed. There were no statistical differences between viruses using a one-
way ANOVA and a Bonferroni multiple comparison post test. (C) MDCK cells were grown on glass coverslips and infected with rWSN or rWSN NS1 D39X viruses at a MOI of
5 TCID50/cell. Infected cultures were ﬁxed at 6 hpi and NS1 localization determined by immunoﬂuorescence microscopy using deconvolution of serial optical sections. All
images were taken with a 100 objective and DAPI was used to counterstain the nucleus. Mock-infected MDCK cells were included in all experiments and showed no
reactivity with the NS1 antibodies.
Fig. 5. Inﬂuenza A virus NS1 protein localization is not affected by R35A and D39X mutations after cDNA transfection. MDCK cells were transfected with plasmids encoding
the indicated proteins. At 9 hours post transfection, NS1 localization was determined by immunoﬂuorescence microscopy using deconvolution of serial optical sections. All
images were taken with a 100 objective and DAPI was used to counterstain the nucleus. MDCK cells transfected with control plasmids showed no reactivity with the NS1
antibody.
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or YFP1-NS1 R35A with YFP2 NS1. When NS1 wild type was
expressed with NS1 R35A, YFP MFI levels were higher than that
seen with NS1 R35A, but not as high as NS1 wild type (Fig. 7B gray
bars). Overall levels of NS1 expression remained consistent (Fig. 7C
gray bars). This indicates that each of the arginine residues
contributes to the NS1 dimer stability and that having one wild
type NS1 can partially stabilize the dimer.
The mutations at NS1 D39 were tested for their effects on NS1
R35A dimerization. MDCK cells were transfected with YFP1/YFP2
constructs encoding each of the NS1 R35A D39X proteins (Fig. 7A
construct with diagonal lines). The YFP expression in each of the
NS1 R35A D39X expressing cells was signiﬁcantly higher than that
observed in NS1 R35A expressing cells (Fig. 7B bars with diagonal
lines). The NS1 protein expression levels were similar across all
constructs (Fig. 7C) indicating that the increased YFP was a result
of increased protein dimerization and not due to increased overall
protein expression levels. The cells transfected with NS1 R35A
D39A constructs had similar levels of YFP ﬂorescence when
compared to NS1 wild type expressing cells, while the cells
expressing NS1 R35A D39N or NS1 R35A D39Y expressed YFP
MFI levels that were lower than that observed in NS1 wild type
expressing cells. The degree of dimerization conferred by the D39X
mutation seems to correlate with the overall replication of the
recombinant viruses, with the NS1 R35A D39A protein having
restored NS1 dimerization and recombinant virus replication more
effectively on MDCK cells than either NS1 R35A D39N or NS1 R35A
D39Y (Fig. 3A). These data supports the hypothesis that the D39
mutations partially restore the ability of NS1 R35A proteins to
dimerize, thus allowing for recombinant virus replication.
Discussion
The NS1 N-terminal RNA binding domain has many functions
important for inﬂuenza A virus replication. RNA binding requires
the dimerization of NS1 which brings together the R38 and K41
residues from each monomer in a conformation optimal for
interaction with the phosphate backbone of the RNA molecule
(Nemeroff et al., 1995; Wang et al., 1999). The N-terminal domain
also contains a nuclear localization sequence, NLS1, which over-
laps some of the same amino acids important to RNA binding and
NS1 dimerization (Wang et al., 1999). This sequence is highly
conserved in NS1 among inﬂuenza A virus strains (Melen et al.,
2007). Changing R38 or R38/K41 to alanine causes loss of RNA
binding and attenuates NS1 function (Donelan et al., 2003; Min
and Krug, 2006; Melen et al., 2007; Newby et al., 2007). In this
study, we demonstrated that the NS1 R38A virus, which has a loss
of RNA binding in addition to disrupting NLS1, has reduced virus
replication and changes in NS1 protein localization, consistent
with our previous results (Newby et al., 2007). Changes at NS1
positions 37 and 41 did not signiﬁcantly affect virus replication
and had minimal effects on NS1 localization, including loss of
nucleolar localization in the virus with the NS1 K41A mutation.
Since nucleolar localization of NS1 varies widely between human
inﬂuenza A virus strains and eliminating nucleolar localization of
NS1 does not adversely affect the replication of inﬂuenza A/Udorn/
72 (Melen et al., 2007), it is unclear how signiﬁcant the NS1
nucleolar localization signals are for virus replication in MDCK and
Vero cells.
Because single alanine mutations do not appear to exclude the
protein from the nucleus, it may be that the dimer conformation of
Fig. 6. Expression levels of Inﬂuenza A virus NS1 proteins. MCDK cells were
transfected with plasmids encoding the indicated proteins. At nine hours post
transfection, NS1 expression was quantiﬁed by ﬂow cytometry. The MFI of the NS1
positive cells was determined and the mean and standard error of the mean are
graphed. Signiﬁcant differences between rWSN NS1 and rWSN are indicated with
an asterisk (n), po0.01 using a one-way ANOVA and a Bonferroni multiple
comparison post test. MDCK cells transfected with control plasmids showed no
reactivity with the NS1 antibody.
Fig. 7. NS1 protein dimerization is affected by mutations at positions R35 and D39.
(A) MDCK cells were cotransfected with plasmids encoding YFP-1 and YFP-2 NS1
fusion proteins with a ﬂexible linker (L) region separating the two domains.
X indicates A, N, or Y at position 39. (B) and (C) At 9 hours post transfection, NS1
expression levels and YFP ﬂuorescence were quantiﬁed by ﬂow cytometry. The
mean ﬂuorescence intensity (MFI) of the NS1 positive cells was determined and the
relative mean and standard error of the mean are graphed. Signiﬁcant differences
between wild type NS1 and other NS1 constructs are indicated with an asterisk (*)
and signiﬁcant differences between NS1 R35A and other NS1 constructs are
indicated with a double cross (‡), po0.01, one-way analysis of variance (ANOVA)
and a Bonferroni multiple comparison post test. Labels indicate the amino acid at
positions 35 and 39 (35/39) with wild type NS1 sequence being R/D. Dotted line at
y¼0.42 represents background YFP ﬂorescence using YFP1 and YFP2-NS1. Data is
normalized to NS1 wild type (R/D) constructs and averaged between three
experiments.
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the NS1 protein brings enough basic amino acids together to form
a functional nuclear localization signal, or that NS1 enters the
nucleus by an alternate mechanism. The lack of a strong pheno-
type calls into question the importance of NLS1 on NS1 protein
function. While the NS1 dimer is required for RNA binding, the
NS1 monomer is small enough to diffuse into the nucleus unaided
(Talcott and Moore, 1999). The high degree of sequence conserva-
tion seen in this region of the NS1 protein may be due to other
functions of those amino acids, including binding RNA or stabiliza-
tion of protein dimers.
When the NS1 amino acid mutation R35A was introduced into
the NS segment, recombinant virus was produced, but every
characterized isolate presented an additional mutation at aspartic
acid at position 39. As R35 has been identiﬁed as important to NS1
dimerization, it was hypothesized that the mutations in R39 were
compensating for loss in dimerization. Previous work that inves-
tigated the NS1 protein with mutations at R35 used plasmid
expressed proteins rather than infectious virus (Wang et al.,
1999; Melen et al., 2007). It may be that the NS1 R35A mutation
not only disrupts NS1 dimerization, but it may also adversely affect
other aspects of virus replication and thus prevent recombinant
virus rescue. When Li et al. (2010) attempted to insert a six
amino acid tag into the RNA binding domain speciﬁcally within
the alpha helixes, they were also unable to rescue virus. This
effect is surprising as inﬂuenza A viruses with the NS1 protein
deleted have been rescued in other virus strains (Garcia-Sastre
et al., 1998).
Structural studies of the NS1 RNA binding domain have described
many intermolecular interactions between various amino acids at the
dimer interface and between the NS1 dimer and RNA. R35 interacts
with both D12 and D39 via salt bridges (Chien et al., 1997). Direct
hydrogen bonding between R35 and D12 and water-mediated hydro-
gen bonding between R35/D12 and R19/D39 have also been described
(Liu et al., 1997) as well as hydrogen bonding between R35 and R46
(Cheng et al., 2009). Cheng et al. (2009) examined the interactions
between the NS1 dimer and RNA, and described R35 and R38
interacting directly with RNA via hydrogen bonds, while D39 and
R41 interact via water-mediated hydrogen bonds. A number of
arginine and aspartic acid residues are found at the NS1–NS1 dimer
interface near the NS1–RNA interface and protein stabilizing salt
bridges commonly form between oppositely charged arginine and
aspartic acid (Chien et al., 1997; Kumar and Nussinov, 2002). This is
supported by previous data indicating that arginines and aspartic
acids at the dimer interface are critical for NS1 dimerization (Wang
et al., 1999). When the positively charged R35 is changed to a neutral
alanine, the dimerization of NS1 is disrupted (Wang et al., 1999).
Under the selective pressure in the recombinant virus rescue system,
we identiﬁed compensatory mutations at D39. The location of the
compensatory mutations supports a direct interaction between R35
and D39 as proposed by Chien et al. (1997). When protein dimeriza-
tion was assessed with the BiFC system, the NS1 R35A proteins were
not able to dimerize to the same extent as NS1 wild type. This could
be due to not only loss of interaction with D39, but also weak
repulsion from the unpaired negative charge of aspartic acid at
position 39. The dimerization defect could be partially corrected either
by one copy of wild type NS1 in the dimer or throughmutation of D39
to an amino acid with less negative charge (A, N, or Y), though in both
cases the extent of dimerization was lower than NS1 wild type. When
NS1 R35A interacts with wild type NS1, the interaction between R35
on the wild type protein and the D39 on the NS1 R35A mutant may
be enough to stabilize the dimer even though the other 35–39 pair
interaction might have a weak repulsion. Conversely, when both R35
and D39 are changed to less charged amino acids, the protein may be
able to dimerize because there is no repulsion from an unpaired
aspartic acid at the dimer interface and other interactions between the
two monomers are enough to stabilize the dimer. These data support
the idea that in addition to the previously identiﬁed, D12, R19, D29,
R35, and R36 (Wang et al., 1999), D39 should be added to the list of
residues important for dimer stability.
The NS1 R35A D39X viruses were able to replicate in MDCK and
Vero cells, though viruses with NS1 D39N and D39Y replicated less
efﬁciently than wild type virus in MDCK but not Vero cells. This
may indicate an incomplete recovery of NS1 function in these
viruses and suggests that NS1 function is more important in MDCK
cells than in the IFN-incompetent Vero cells, consistent with our
previous observations (Newby et al., 2007). While the localization
of the NS1 protein was similar between the three NS1 R35A D39X
viruses, it was different from wild type virus, most obviously
through the appearance of cytoplasmic puncta of NS1. Similar to
the viruses with NS1 R38A or K41A, no nucleolar localization of
NS1 was seen in cells infected with viruses expressing the NS1
R35A D39X proteins. While the strain speciﬁc NoLS has been
identiﬁed at the C terminus of the NS1 protein, interaction with
nucleolin, a major nucleolar protein, has been mapped to the RNA
binding domain (Melen et al., 2007; Murayama et al., 2007).
Changes in the RNA binding domain that disrupt the NS1–
nucleolin interaction could explain the loss of nucleolar localiza-
tion seen in some of the NS1 mutants. Replication of a virus
encoding NS1 R38A K41A was enhanced by a mutation in NS1
(S42G) (Donelan et al., 2003). This mutation did not alter NS1 RNA
binding activity but we speculate that perhaps it improved NS1
dimer formation, analogous to the D39X mutations we identiﬁed.
Dimerization of the NS1 protein is required for RNA binding,
and RNA binding has an important role in NS1 function and viral
pathogenesis. The BiFC assays indicate that the ability of NS1
to interact is dramatically decreased with an R35A mutation.
If interfering with dimerization or the structural stability of the
RNA binding domain as seen here and elsewhere (Li et al., 2010) is
so detrimental that the resulting virus is not viable, then the
dimerization interface of the RNA binding domain could be a
viable drug target. If the R35A viruses were not viable or strongly
outcompeted by low frequency D39X mutations, this indicates
that blocking dimerization can have a dramatic effect on virus
replication. The NS1 protein has been identiﬁed as a potential drug
target (Maroto et al., 2008; Basu et al., 2009; Jablonski et al., 2011;
Walkiewicz et al., 2011). Previous studies on potential ligand
binding sites in inﬂuenza NS1 identiﬁed 2 sites in the RNA binding
domain that would interact with R35 or D39 (Darapaneni et al.,
2009), and at least one potential drug, baicalin, has been shown to
interact with R35, R38, and D39 (Nayak et al., 2014).
Materials and methods
Cell culture
MDCK and 293T cells were cultured in Dulbecco's Modiﬁed Eagle
Medium (DMEM, Sigma) supplemented with 100 U/ml penicillin,
100 μg/ml streptomycin (Gibco), 2 mM glutamax (Gibco) and 10%
fetal bovine serum (FBS, Hyclone). During infection, MDCK cells
were maintained in infectious media, consisting of DMEM with
penicillin/streptomycin, glutamax, 0.15% BSA (Sigma), and 4 μg/ml
N-acetyl trypsin (Sigma) (DMEM infectious media). During virus
rescue, 293T cells were maintained in OptiMEM (Gibco) or OptiMEM
with 0.1% FBS.
Plasmids
All plasmids were ampliﬁed in chemically competent DH5
alpha Escherichia coli. Mutations to the pHH21 NS segment
plasmid were introduced using four primer PCR (Table 2). Forward
and reverse primers FluA6 and FluA5 were used along with
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mutagenesis primers NS1 R35A f and NS1 R35A r 2 for the R35A
mutation, NS1 R37A F and NS1 R37A r 2 for R37A, and NS1 K41A f
and NS1 K41A r for the K41A mutation. Sequences were introduced
into pHH21 plasmids using restriction enzyme digest followed by
DNA ligation. The NS coding region for all plasmids was conﬁrmed
by sequencing.
NS1 cDNAs were cloned into the pCAGGS vector (Niwa et al.,
1991). A myc tag with the amino acid sequence EQKLISEEDL was
added to the C-terminus of NS1 using the WSN 50 NS1 into PC and
wsnmyctag primers (Table 2) and introduced into the pCAGGS
plasmid using restriction enzyme digest followed by DNA ligation.
NS1 R35A D39X mutations were introduced into a NS1-myc cDNA
expression plasmid by amplifying NS1 sequences from virus with
50 primers WSN 50 NS1 into PC or WSN 50 NS1 into PC EcoR1 (for
R35A D39A) and 30 primer WSN 30 NS1 into PC and introduced into
a pCAGGS NS1-myc plasmid by restriction enzyme digest and
ligation. The NS1 coding region of all plasmids was veriﬁed by
sequencing.
Plasmids used for Bimolecular Florescence Complementation
(BiFC) were kindly provided by Matt Frieman, University of Mary-
land (Nyfeler et al., 2005; Frieman et al., 2007). NS1 sequences
were introduced downstream of either an N terminal fragment of
Venus YFP (YFP1; amino acids 1–158) or the C terminal fragment
of Venus YFP (YFP2; amino acids 159–239) via a 10 amino acid
linker (GGGGSGGGGS) (Fig. 7A). Primers WSN 50 NS1 into split YFP
and WSN 30 NS1 into split YFP (Table 2) were used to amplify the
NS1 sequences that were then introduced in the YFP1 or YFP2
plasmids by restriction enzyme digest and ligation.
Viruses
Recombinant A/WSN/33 inﬂuenza viruses (rWSN) were res-
cued using a 12 plasmid reverse genetics system as previously
described (Neumann et al., 1999). Mutations were introduced into
the pHH21 NS plasmid as described above. Recombinant viruses
were rescued by transfecting 293T cells with the 12 plasmids and
20 μl TransIT-LT1 (MirusBio) in OptiMEM. Twenty four hours after
transfection, media was changed to OptiMEM with 0.1% FBS.
Supernatants were collected from the transfected cells every
24 h and virus was detected by hemagglutination assay.
Hemagglutination assay
Hemagglutination was assessed using 0.5% chicken red blood
cells (CBT farms, Chestertown MD) in Alsevier's solution. Rescue
supernatants were diluted in a series of two fold dilutions in PBS.
When supernatants showed hemagglutination activity, infectious
virus was isolated by plaque assay.
Plaque assay
Supernatants were diluted in a serial 10 fold dilution series in
DMEM infectious media and applied to monolayers of MDCK cells
in 6-well plates for 1 h with rocking at room temperature. Cells
were then overlaid with 1% agarose in DMEM infectious media.
Cultures were incubated for 3 days and checked for plaque
formation by phase contrast microscopy. When plaques were
visible, agarose plugs above individual plaques were isolated and
stored in 1 ml of DMEM infectious media.
Virus infections
MDCK cells were infected at the indicated multiplicity of
infection (MOI). Virus was diluted to the appropriate concentra-
tion in DMEM infectious media. Cells were washed twice with
phosphate buffered saline with calcium and magnesium (PBSþ)
(Gibco) before being infected. Cells with virus inoculum were
incubated for 1 h at room temperature with rocking and then the
inoculum was removed. The cells were then washed twice in
PBSþ before adding additional DMEM infection media. Seed
stocks of virus were grown by infecting MDCK cells with 100 μl
of plaque pick solution. Working stocks were grown by infecting
MDCK cells at an MOI of 0.01 TCID50/cell from seed stocks. RNA
was isolated from the resulting virus stocks and the NS segment
coding region was sequenced and veriﬁed.
Table 2
Primer sequences used in plasmid development and sequencing.
Primer name Primer sequence Direction Purpose
FluA5 ATACGTCTCGTATTAGTAGAAACAAGGGTGTTTTTT Reverse 1–3
FluA6 CGACGTCTCCGGGAGCAAAAGCAGGGTG Forward 1–3
NS1 R35A f CCATTCCTTGATGCTCTTCGCCGAGAT Forward 4
NS1 R35A r 2 CTGATCTCGGCGAAGAGCATCAAGGAATGGG Reverse 4
NS1 R37A f CTTGATCGGCTTGCTCGAGATCAG Forward 4
NS1 R37A r 2 CTTCTGATCTCGAGCAAGCCGATCAAGGAATGGG Reverse 4
NS1 K41A f CGAGATCAGGCGTCCCTAAGAGGAAG Forward 4
NS1 K41A r CTTCCTCTTAGGGACCGCTGATCTCG Reverse 4
WSN 30 NS1 into PC ATAATAGAGCTCACCATGGATCCAAACACTGTGTCAAGC Reverse 5
WSN 50 NS1 into PC EcoR1 GGCAAAGAATTCGAGCTCACCATGGATCCAAACACTGTGTCAAG Forward 5
WSN 50 NS1 into PC ATAAAACCCGGGTCAAACTTCTGACCTAATTGTTCCCGC Forward 5
wsnmyctag ATAATACCCGGGTCACAAGTCTTCTTCGCTGATGAGTTTCTGCTCAACTTCTGACCTAAT Reverse 5
pCAGGS fwd for seq GCAACGTGCTGGTTGTTGTGC Forward 3
pCAGGS rev for seq CAAGGGGCTTCATGATGTC Reverse 3
WSN 50 NS1 into split YFP CGAGTCCGGAATGGATCCAAACACTGTGTCAAGC Forward 6
WSN 30NS1 into split YFP GCATGTCTAGATCAAACTTCTGACCTAATTGTTCCCGC Reverse 6
T7 Promotor TAATACGACTCACTATAGG Forward 7
BGH Rev TAG AAG GCA CAG TCG AGG Reverse 7
1: Inﬂuenza genome RT-PCR sequencing.
2: pHH21 cloning.
3: Sequencing.
4: Introduce mutation into NS1.
5: Amplifying NS1 for insertion into pCAGGs.
6: Amplifying NS1 for insertion into split YFP plasmids.
7: Sequencing YFP domain and NS1 in split YFP plasmids.
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TCID50 assay
To determine the infectious virus titer, virus supernatants were
diluted in a serial 10 fold dilution series from 101 to 108 in
DMEM infectious media. MDCK cells were grown to conﬂuence in
96 well plates and washed twice with PBSþ before 100 μl of each
virus dilution was added to each of 6 wells. The cells were
incubated at 37 1C for 4 days. The cells were then ﬁxed by adding
an equal volume of 4% formaldehyde (Fisher Scientiﬁc), followed
by staining with napthol blue-black solution. Titer was determined
by calculating the number of cleared wells at each dilution using
Reed and Muench's calculations (1938).
Transfections
Conﬂuent MDCK cells were trypsinized and transfected in
suspension then plated at 30% density. For pCAGGS NS1-myc
plasmids, 3 μg of DNA was added with 6 μl of Lipofectamine
2000 (Invitrogen). For Bimolecular Florescence complementation,
3 μg of each plasmid was added with 6 μl of Lipofectamine 2000.
DNA and Lipofectamine were ﬁrst mixed separately with Opti-
mem, incubated for 5 min, then combined and incubated for
20 min before being added dropwise to the MDCK cells in
suspension. Nine hours post transfection, cells were processed
for microscopy or ﬂow cytometry as described below.
SDS PAGE and Western blot
MDCK cells infected at an MOI of 5 TCID50/cell were washed
with PBS 6 hours post infection and lysed in 1% SDS (Sigma) in
PBS. Cell lysates were processed by pressing through a 26 5/8G
needle (Becton Dickinson) and mixing 3:1 with a 4 SDS PAGE
loading buffer before heating for 5 min at 95 1C. Samples were
loaded alongside Precision plus Protein all blue ladder (Biorad)
onto a 15% polyacrylamide gel with a 3% polyacrylamide stacking
gel for protein separation and run at 150 V through the stacking
gel and 100 V through the separating gel. Proteins were trans-
ferred from the gel to a polyvinylidene diﬂuoride (PVDF) Immo-
bilon FL membrane (Millipore) at 20 V overnight at 4 1C.
Membranes were blocked in PBS, 0.3% Tween-20, 5% non-fat dry
milk for 1 h at room temperature (blocking solution). Membranes
were then incubated for 1 h in primary antibodies (mouse anti-
NS1 6A4 or 2H6 (kindly provided by Yee-Joo Tan; Tan et al., 2010))
1:10,000 and mouse anti-beta-actin antibody (Abcam) 1:10,000
diluted in blocking solution. After incubation they were washed
three times for 5 min each time in PBS with 0.3% Tween-20
(Sigma-Aldrich), then incubated for 1 h in with secondary anti-
body goat anti-mouse conjugated to Alexa Fluor 647 (Molecular
Probes) 1:1000 diluted in blocking solution and again washed
3 times with PBSþ0.3% Tween-20. All membrane incubation and
wash steps took place at room temperature. Protein bands were
detected using a Fuji FLA 5000 phosphoimager. Mock-infected
MDCK cells showed no reactivity with the NS1 antibody.
Immunoﬂorescence microscopy
MDCK cells were grown on glass coverslips before being
infected or transfected in solution and plated onto glass coverslips.
At indicated times after infection or transfection, cells were
washed two times with PBSþ and ﬁxed with 2% paraformalde-
hyde (Sigma-Aldrich) in PBS for 15 min at room temperature. Cells
were then washed twice with PBS and permeabilized with 0.2%
Triton-X 100 (sigma X100) in PBS for 15 min at room temperature.
Cells were washed after each step by dipping coverslips in PBS
with 0.2% Tween-20 15 times. Cells were blocked in PBS with 3%
goat serum (Sigma) and 0.5% BSA (Calbiochem) (blocking buffer)
for 1 h and then washed. Cells were then incubated in primary
antibody mouse anti-NS1 (1A7CL kindly provided by Robert
Webster (Brown et al., 1983)) at a 1:100 dilution in blocking buffer
for 1 h, washed, and then incubated with goat anti-mouse anti-
body conjugated to Alexa Fluor 488 (molecular probes A-11029)
and DAPI (Invitrogen) in blocking buffer, washed by dipping 10
times in PBS with 0.2% Tween-20 and ﬁve times in MilliQ water.
Coverslips were mounted cell side down in Prolong gold antifade
(Invitrogen). Cells were imaged on a Nikon 90-i microscope using
Volocity software for image acquisition. Images were taken with a
100 objective in Z-stack mode and deconvoluted using Volocity
software and calculated point spread functions. Mock-infected or
control-transfected cells showed no reactivity with the NS1
antibody.
Flow cytometry
At 6 hours post infection or 9 hours post transfection, cells
were washed two times with PBS and incubated with 0.2%
trypsin–EDTA (Invitrogen) in PBS for 20 min. The cells were then
ﬁxed with 2% paraformaldehyde (Sigma-Aldrich) in PBS for 15 min
at room temperature and centrifuged at 300g for 5 min. Cells were
then washed twice with PBS with centrifugation between each
wash and permeabilized with 0.2% Triton-X 100 (Sigma) for
10 min at room temperature. Cells were washed two more times
in PBS and incubated in PBS with 3% goat serum (Sigma) and 0.5%
BSA (Calbiochem) (blocking buffer) for 1 h. Cells were then
incubated with mouse anti-NS1 (1A7CL) at a dilution of 1:100 in
blocking buffer for 1 h at room temperature, washed three times,
and then incubated with goat anti-mouse antibody conjugated to
Alexa Fluor 647 in blocking buffer for 1 h at room temperature,
and washed three times in PBS. All wash steps were done by
centrifuging at 300g for 5 min and removing the supernatant with
a vacuum aspirator comb (VP Scientiﬁc BP). The NS1 antibody did
not react with mock-infected MDCK cells (data not shown).
For pCAGGS NS1 myc experiments, transfected cells expressing
NS1 were analyzed for Mean Florescent Intensity (MFI) using the
anti-NS1 antibody (1A7CL). For BiFC experiments, transfected cells
were also gated by positive NS1 ﬂorescence, and both the NS1 MFI
and the YFP MFI were analyzed for this group of cells. Cells were
analyzed on BD FACSCaliber and the data was processed using
FlowJo 7.6.4 software.
Statistical analysis
Low MOI growth curves were analyzed using a two-way
Analysis of Variance using Graph Pad Prism 6. Growth curve
treatment groups were sampled in triplicate. Plaque diameter
and the MFI in ﬂow cytometry experiments were analyzed using
a one-way analysis of variance using graph pad prism 6. MFI of
gated cells was normalized to wild type protein expression and
represent 3 experiments combined.
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